Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Ibulief I.V. Injection launched for patent ductus arteriosus in premature infants

June 15, 2018

Application for Furoscix receives complete response letter from the FDA

June 14, 2018

Pluristem presents topline results from phase II study of PLX-PAD cells

June 13, 2018

Amgen presents new apelin receptor agonists

June 11, 2018

MyoKardia opens phase III study of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy

June 8, 2018

MannKind announces completion of phase I study of TreT in pulmonary arterial hypertension

June 8, 2018

Amgen identifies new apelin receptor agonists

June 6, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

Hefei Co-Source Pharmaceuticals and Anhui Blooming Drug Safety Evaluation patent steroids

May 24, 2018

RARI-049, a novel Nampt inhibitor for treating pulmonary hypertension

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...